Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer

Overview

Journal Ann Surg

Specialty General Surgery

Date 2015 Mar 31

PMID 25822675

Citations 30

Authors

Patricia A Parker

Susan K Peterson

Isabelle Bedrosian

Melissa A Crosby

Yu Shen

Dalliah M Black

Gildy Babiera

Henry M Kuerer

Jun Ying

Wenli Dong

Scott B Cantor

Abenaa M Brewster

Affiliations

Soon will be listed here.

Abstract

Objective: We prospectively examined the psychosocial predictors and the decision-making process regarding contralateral prophylactic mastectomy (CPM) among women with sporadic breast cancer.

Background: Increasing numbers of women with breast cancer are seeking CPM. Data are limited about the surgical decision-making process and the psychosocial factors that influence interest in CPM.

Methods: Women with early-stage unilateral breast cancer (n = 117) were recruited before their first surgical visit at MD Anderson and completed questionnaires assessing knowledge of and interest in CPM and associated psychosocial factors. After the appointment, women and their surgeons completed questions about the extent that various surgical options (including CPM) were discussed; also, the women rated their perceived likelihood of having CPM and the surgeons rated the appropriateness of CPM.

Results: Before their first visit, 50% of women were moderately to extremely interested in CPM and 12 (10%) of women had CPM at the time of their primary breast cancer surgery. Less knowledge about breast cancer (P = 0.02) and greater cancer worry (P = 0.03) predicted interest in CPM. Greater cancer worry predicted who had CPM (P = 0.02). Interest in CPM before surgical visit and the likelihood of having CPM after the visit differed (P ≤ 0.001). Surgeons' rating of the appropriateness of CPM and the patient's reported likelihood of having CPM were not significantly different (P = 0.49).

Conclusions: Interest in CPM is common among women with sporadic breast cancer. The informational and emotional aspects of CPM may affect the decision to have CPM and should be addressed when discussing surgical options.

Citing Articles

Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer.

Benedict C, Nouriani B, Neri E, Miller K, Kurian A, Gross J Cancer Med. 2024; 13(23):e70357.

PMID: 39653041 PMC: 11627588. DOI: 10.1002/cam4.70357.

Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?.

Mamtani A, Sjoberg D, Vincent A, Ehdaie B, Malhotra D, Vickers A Breast Cancer Res Treat. 2023; 199(1):119-126.

PMID: 36881270 PMC: 10542969. DOI: 10.1007/s10549-023-06891-6.

Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.

Hrebinko K, Bryce C, Downs-Canner S, Diego E, Myers S Cancer. 2022; 128(12):2258-2268.

PMID: 35389517 PMC: 10964149. DOI: 10.1002/cncr.34207.

Peace of Mind: A Role in Unnecessary Care?.

Chen M, Hughes T, Dossett L, Pitt S J Clin Oncol. 2021; 40(5):433-437.

PMID: 34882501 PMC: 8824400. DOI: 10.1200/JCO.21.01895.

Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001).

Pfob A, Mehrara B, Nelson J, Wilkins E, Pusic A, Sidey-Gibbons C Breast. 2021; 60:111-122.

PMID: 34619573 PMC: 8551470. DOI: 10.1016/j.breast.2021.09.009.

References

Tuttle T, Jarosek S, Habermann E, Arrington A, Abraham A, Morris T . Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009; 27(9):1362-7. DOI: 10.1200/JCO.2008.20.1681. View

Fox S, Heritage J, Stockdale S, Asch S, Duan N, Reise S . Cancer screening adherence: does physician-patient communication matter?. Patient Educ Couns. 2009; 75(2):178-84. DOI: 10.1016/j.pec.2008.09.010. View

Jones N, Wilson J, Kotur L, Stephens J, Farrar W, Agnese D . Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009; 16(10):2691-6. DOI: 10.1245/s10434-009-0547-9. View

Frost M, Slezak J, Tran N, Williams C, Johnson J, Woods J . Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005; 23(31):7849-56. DOI: 10.1200/JCO.2005.09.233. View

Yao K, Stewart A, Winchester D, Winchester D . Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010; 17(10):2554-62. DOI: 10.1245/s10434-010-1091-3. View

Cash T, Grasso K . The norms and stability of new measures of the multidimensional body image construct. Body Image. 2007; 2(2):199-203. DOI: 10.1016/j.bodyim.2005.03.007. View

King T, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M . Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011; 29(16):2158-64. DOI: 10.1200/JCO.2010.29.4041. View

Bowen D, Patenaude A, Vernon S . Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev. 1999; 8(4 Pt 2):326-8. View

Lostumbo L, Carbine N, Wallace J, Ezzo J . Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004; (4):CD002748. DOI: 10.1002/14651858.CD002748.pub2. View

10.

Kollias J, Ellis I, Elston C, Blamey R . Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999; 25(6):584-9. DOI: 10.1053/ejso.1999.0711. View

11.

Bedrosian I, Hu C, Chang G . Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010; 102(6):401-9. PMC: 4415082. DOI: 10.1093/jnci/djq018. View

12.

Gershenwald J, Hunt K, Kroll S, Ross M, Baldwin B, Feig B . Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998; 5(6):529-38. DOI: 10.1007/BF02303646. View

13.

Mehta S, Lubeck D, Pasta D, Litwin M . Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003; 170(5):1931-3. DOI: 10.1097/01.ju.0000091993.73842.9b. View

14.

Tuttle T, Habermann E, Abraham A, Emory T, Virnig B . Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Rev Anticancer Ther. 2007; 7(8):1117-22. DOI: 10.1586/14737140.7.8.1117. View

15.

Mishel M . Adjusting the fit: development of uncertainty scales for specific clinical populations. West J Nurs Res. 1983; 5(4):355-70. DOI: 10.1177/019394598300500408. View

16.

Montgomery L, Tran K, Heelan M, Van Zee K, Massie M, Payne D . Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999; 6(6):546-52. DOI: 10.1007/s10434-999-0542-1. View

17.

Fagerlin A, Lakhani I, Lantz P, Janz N, Morrow M, Schwartz K . An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns. 2006; 64(1-3):303-12. DOI: 10.1016/j.pec.2006.03.010. View

18.

OConnor A, Tugwell P, Wells G, Elmslie T, Jolly E, Hollingworth G . A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998; 33(3):267-79. DOI: 10.1016/s0738-3991(98)00026-3. View

19.

Nekhlyudov L, Bower M, Herrinton L, Altschuler A, Greene S, Rolnick S . Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005; (35):55-60. DOI: 10.1093/jncimonographs/lgi038. View

20.

Tuttle T, Habermann E, Grund E, Morris T, Virnig B . Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007; 25(33):5203-9. DOI: 10.1200/JCO.2007.12.3141. View